[Congressional Bills 108th Congress]
[From the U.S. Government Publishing Office]
[H.R. 4531 Introduced in House (IH)]






108th CONGRESS
  2d Session
                                H. R. 4531

To authorize the Secretary of Health and Human Services to conduct and 
          support research using human pluripotent stem cells.


_______________________________________________________________________


                    IN THE HOUSE OF REPRESENTATIVES

                              June 9, 2004

 Mr. Ackerman introduced the following bill; which was referred to the 
                    Committee on Energy and Commerce

_______________________________________________________________________

                                 A BILL


 
To authorize the Secretary of Health and Human Services to conduct and 
          support research using human pluripotent stem cells.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Ronald Reagan Memorial Stem Cell 
Research Act of 2004''.

SEC. 2. AUTHORITY FOR FEDERAL SUPPORT OF RESEARCH USING HUMAN STEM 
              CELLS.

    (a) In General.--The Secretary of Health and Human Services, acting 
through the Director of the National Institutes of Health, shall in 
accordance with this section conduct and support research using human 
pluripotent stem cells.
    (b)  Conditions for Funding of Research; Compliance With 2000 NIH 
Final Guidelines.--A condition for the conduct or support of research 
under subsection (a) is that the research be conducted in compliance 
with the final guidelines regarding such research that were issued by 
the National Institutes of Health and published in the Federal Register 
on August 25, 2000 (65 FR 51976 et seq.), including provisions 
regarding informed consent and provisions regarding areas of research 
that are ineligible for funding. The preceding sentence applies without 
regard to any Federal administrative policies regarding such research 
established after the publication of such guidelines, including 
restrictions on the sources of human pluripotent stem cells.
    (c) Authorization of Appropriations.--For the purpose of carrying 
out this section, there are authorized to be appropriated $87,000,000 
for fiscal year 2005, and such sums as may be necessary for each 
subsequent fiscal year.
                                 <all>